EP 1225866 A4 20040421 - METHOD AND COMPOSITIONS FOR TREATING PULMONARY DISEASES
Title (en)
METHOD AND COMPOSITIONS FOR TREATING PULMONARY DISEASES
Title (de)
METHODE UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN
Title (fr)
PROCEDE ET COMPOSITIONS POUR TRAITER DES MALADIES RESPIRATOIRES
Publication
Application
Priority
- US 0030113 W 20001101
- US 16315899 P 19991102
Abstract (en)
[origin: WO0132127A2] This invention relates to treating pulmonary diseases such as chronic obstructive pulmonary disease or asthma by administering a phosphodiesterase 4 inhibitor in combination with anti-inflammatory corticosteroid.
IPC 1-7
A61K 31/575; A61K 31/58; A61K 31/275; A61K 31/4439; A61K 31/44; A61P 11/00
IPC 8 full level
A61K 31/275 (2006.01); A61K 31/573 (2006.01); A61K 31/575 (2006.01); A61K 31/58 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); A61K 45/00 (2006.01)
CPC (source: EP KR)
A61K 31/56 (2013.01 - KR); A61K 31/575 (2013.01 - EP); A61K 31/58 (2013.01 - EP); A61P 11/00 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
C-Set (source: EP)
Citation (search report)
- [X] DE 4332041 A1 19950323 - RENTSCHLER ARZNEIMITTEL [DE]
- [A] WO 9500139 A1 19950105 - SMITHKLINE BEECHAM CORP [US], et al
- [XY] TORPHY T J ET AL: "ARIFLO (SB 207499), A SECOND GENERATION PHOSPHODIESTERASE 4 INHIBITOR FOR THE TREATMENT OF ASTHMA AND COPD: FROM CONCEPT TO CLINIC", PULMONARY PHARMACOLOGY AND THERAPEUTICS, ACADEMIC PRESS, NEW YORK, NY, US, vol. 12, no. 2, 1999, pages 131 - 135, XP001155797, ISSN: 1094-5539
- [Y] NORMAN P: "PDE4 inhibitors 1999", EXPERT OPINION ON THERAPEUTIC PATENTS 1999 UNITED KINGDOM, vol. 9, no. 8, 1999, pages 1101 - 1118, XP001058161, ISSN: 1354-3776
- [X] MURDOCH R ET AL: "The addition of SB 207499 (ARIFLO), a novel and selective PDE4 inhibitor, to oral prednisolone, is safe and well tolerated", EUROPEAN RESPIRATORY JOURNAL, vol. 12, no. SUPPL. 28, September 1998 (1998-09-01), European Respiratory Society Annual Congress;Geneva, Switzerland; September 19-23, 1998, pages 362S, XP009026674, ISSN: 0903-1936
- [A] SILVESTRE J ET AL: "SB-207499. Antiasthmatic/antiinflammatory phosphodiesterase IV inhibitor", DRUGS OF THE FUTURE 1998 SPAIN, vol. 23, no. 6, 1998, pages 607 - 615, XP000981875, ISSN: 0377-8282
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0132127 A2 20010510; WO 0132127 A3 20011206; AP 2002002496 A0 20020630; AR 029189 A1 20030618; AU 1357501 A 20010514; BG 106748 A 20030228; BR 0015270 A 20020618; CA 2388333 A1 20010510; CN 1387404 A 20021225; CO 5261512 A1 20030331; CZ 20021512 A3 20030416; DZ 3225 A1 20010510; EA 200200518 A1 20021031; EC SP003747 A 20020523; EP 1225866 A2 20020731; EP 1225866 A4 20040421; HK 1049107 A1 20030502; HU P0203152 A2 20030128; HU P0203152 A3 20040628; IL 149367 A0 20021110; JP 2003513028 A 20030408; KR 20020057988 A 20020712; MA 26841 A1 20041220; MX PA02004350 A 20021107; NO 20022057 D0 20020430; NO 20022057 L 20020627; OA 12076 A 20060504; PE 20011005 A1 20010928; PL 355261 A1 20040405; SK 7592002 A3 20021106; TR 200201211 T2 20020821; TW I242431 B 20051101; ZA 200203435 B 20030625
DOCDB simple family (application)
US 0030113 W 20001101; AP 2002002496 A 20001101; AR P000105742 A 20001031; AU 1357501 A 20001101; BG 10674802 A 20020529; BR 0015270 A 20001101; CA 2388333 A 20001101; CN 00815265 A 20001101; CO 00083427 A 20001102; CZ 20021512 A 20001101; DZ 003225 A 20001101; EA 200200518 A 20001101; EC SP003747 A 20001031; EP 00975533 A 20001101; HK 02109234 A 20021219; HU P0203152 A 20001101; IL 14936700 A 20001101; JP 2001534335 A 20001101; KR 20027005609 A 20020501; MA 26621 A 20020502; MX PA02004350 A 20001101; NO 20022057 A 20020430; OA 1200200124 A 20001101; PE 0011682000 A 20001102; PL 35526100 A 20001101; SK 7592002 A 20001101; TR 200201211 T 20001101; TW 89123039 A 20001122; ZA 200203435 A 20020430